Cardiovascular Information Center Archive
MEV aortic valve replacement is noninferior to SEV aortic valve replacement in high-risk patients with aortic stenosis.
Addition of a new class of antihypertensive drugs to existing treatment greatly decreases SBP in previously medicated patients with HT.
Positive emotions and low levels of depression after a cardiovascular disease (CVD) event are associated with low risk for mortality during a 15-year period.
The USPSTF has found that the current evidence is inadequate to assess the benefits and harms of screening with ECG for atrial fibrillation and cardiovascular disease in older adults.
Ginkgo biloba extract, along with aspiring, may help cognition in acute ischemic stroke patients.
Accuracy was 95.8% for DVT diagnosis for general practitioners using compression ultrasonography.
The AAFP continues to use the 2014 JNC8 guideline instead of the 2017 AHA/ACC update.
Blood pressure decreases more than a decade before death in patients older than 60 years.
Increased frequency of television viewing may be linked to an increased risk for venous thromboembolism.
Many direct acting oral anticoagulants may be more beneficial than warfarin.
Low-dose aspirin does not decrease healing time for patients with venous leg ulcers.
Treating patients with ruptured abdominal aortic aneurysms with endovascular strategy over open repair may increase survival and decrease cost.
Preliminary clinical trial results show more heart-related deaths occur in patients taking febuxostat compared to allopurinol.
The AHA and ACC have released a new guideline that categorizes more US adults as hypertensive.
Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.
Dual therapy with dabigatran and a P2Y12 inhibitor resulted in a lower risk of bleeding events compared with triple therapy with warfarin, a P2Y12 inhibitor, and aspirin.
Appropriate use criteria for the treatment of patients with severe aortic stenosis includes the use of surgical aortic valve replacement and transcatheter aortic valve replacement.
Use of PPIs was associated with increased risks of first -time ischemic stroke and MI, particularly among long -term users and at high doses.
Compared with warfarin, treatment with DOACs was not associated with an increased risk of major bleeding or all-cause mortality within the first 90 days.
Compared with nonusers, current statin users experienced markedly decreased risk of CA-SAB.
Among women, but not men, mid-adulthood hypertension correlated with a 65% increased dementia risk.
Patients who discontinued aspirin use experience a higher risk of cardiovascular events.
The report addresses the appropriate use of multiple imaging modalities available for clinicians in the evaluation of valvular heart disease, discussing the spectrum of patients.
The researchers found no long-term increase in either all-cause or cause-specific mortality among women who received hormone therapy for up to 5.6 years or 7.2 years, depending on the type of therapy.
Compared with normal-weight individuals, metabolically healthy obese individuals have an increased risk of coronary heart disease, cerebrovascular disease, and heart failure
In patients with depressive symptoms, vitamin D deficiency with no additional supplements had the highest depressive score at 6 months and shortest cardiac event-free survival.
The statement includes advances in care since the ADA's last position statement was published in 2003.
NT-proBNP-guided treatment strategy did not improve outcomes compared with a usual care strategy in high-risk patients with heart failure.
The findings offer the first strong clinical evidence that inflammation-targeted therapy may reduce the risk of cardiovascular disease.
Men who are admitted to the hospital with a serious infection may have an increased risk of cardiovascular disease in the years immediately following the infection.
The AAP has released an updated clinical practice guideline for the diagnosis and management of high blood pressure in children.
Fondaparinux and rivaroxaban were associated with increased risk of major bleeding in patients who underwent total hip or knee arthroplasty.
Risk-adjusted in-hospital mortality is significantly increased at safety-net hospitals for patients undergoing percutaneous coronary intervention.
The incidence of all strokes decreased over time in men, but not women, due to a decrease in ischemic stroke.
Researchers found higher estimated cardiovascular risks associated with marijuana use than cigarette smoking.
The gene-editing tool called CRISPR-Cas9 could have the potential to treat and prevent other genetic diseases.
The USPSTF updated their 2012 recommendations on behavior lifestyle counseling for preventing cardiovascular disease.
Stopping statin therapy 3 to 6 months after an initial ischemic stroke may increase risk of a recurrent stroke.
Data from a clinical trial show that patients taking daily aspirin were not at heightened risk of being hospitalized for heart failure.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.
Researchers sought to examine the link between intelligence scores during childhood and leading causes of death during the life course.
The use of PAP, compared with no treatment or sham, was not associated with reduced risks of cardiovascular outcomes or death for patients with sleep apnea.
Researchers found that idarucizumab is effective for dabigatran reversal among patients with uncontrolled bleeding and who are undergoing urgent surgery.
Users of opioid-only agents had significantly increased rates of emergency room visits and hospitalizations for ischemic heart disease and IHD-related mortality.
There were 526.86 hospital admissions for every 100,000 people in 2002, compared with 364.66 per 100,000 in 2013.
Clinicians will encounter more patients at risk for CHF as the population ages and cardiovascular risk factors become more prevalent.
The researchers found that during 13,509 patient-years of follow-up, 3166 patients had 405 first bleeding events.
Researchers found that 16% of patients received doses inconsistent with US Food and Drug Administration labeling.
The therapy may be cost-effective for patients with a predicted 1-year VTE risk of 17.5% or more.
Blood pressure levels below the recommended targets lower risk of CVD and all-cause mortality.
Compared with individuals reporting chocolate intake less than once per month, the rate of AF was lower for people consuming chocolate regularly.
The ALLHAT-LLT trial showed that statin therapy for primary cardiovascular prevention may not benefit adults older than 65 years of age.
CVD occurred in 11.8% of participants in the vitamin D group and 11.5% in the placebo group.
The USPSTF recommends that pregnant women receive screening for preeclampsia with blood pressure measurements throughout pregnancy.
Apixaban is associated with a lower risk of gastrointestinal bleeding than rivaroxaban or dabigatran.
Nine million fewer adults would be taking statins if clinicians followed the USPSTF guidelines.
Most patients in primary care with undiagnosed chest pain do not undergo diagnostic testing.
The researchers found heterogeneity in the association between recorded alcohol consumption and the initial presentation of 12 cardiovascular diseases.
Researchers observed a higher incidence of hypertension in patients with knee osteoarthritis compared with patients without osteoarthritis.
The updated guideline includes recent advances in diagnostic imaging and improvements in catheter-based and surgical interventions for patients with valvular heart disease.
A daily dose of atorvastatin could reduce pulmonary artery pressure among patients with COPD.
In older adults, the consequences of functional impairment include increased morbidity and mortality, and reduced ability to perform activities of daily living.
Researchers also observed no difference in 30-day mortality rates between patients in the ICU and those who received regular inpatient care in another hospital unit.
Anticoagulation with dabigatran was associated with fewer bleeding complications compared with warfarin among patients undergoing ablation for atrial fibrillation.
A longer period between P2Y12 inhibitor administration and primary percutaneous coronary intervention improves coronary reperfusion.
Same-day discharge after percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes was not predictive of 30-day readmission, death, or bleeding.
Researchers find that hospitalizations and deaths among heart failure patients are highest during winter months.
Suboptimal intake of 10 specific dietary factors is associated with a substantial proportion of deaths due to heart disease, stroke, or type 2 diabetes.
NSAID use during ARI was associated with a 3.4-fold increased risk of AMI compared with 2.7-fold increased risk without NSAID use.
Electronic cigarettes cause an imbalance of cardiac autonomic tone and increased oxidative stress, which may increase cardiovascular risk.
Higher-potency statins increased hospitalization for community-acquired pneumonia compared with lower-potency statins.
The AHA found that irregular eating patterns are less ideal for maintaining body weight and cardiometabolic health.
Diabetes without insulin did not appear to increase thromboembolic risk in patients with atrial fibrillation treated with anticoagulation.
RASIs reduced cardiovascular events and death only when compared with placebo but not when compared with active controls.
The device has shut down due to an intermittent connection between the battery and electrical contacts.
An estimated 12.3% of Americans over the age of 21 have masked hypertension.
Researchers observed a connection between advancing age, systemic inflammation, cardiovascular disease, and caffeine.
The ACP and the AAFP has released a joint recommendation for the pharmacologic treatment of hypertension in adults aged 60 years and older.
Individuals who perform their physical activity in 1 or 2 sessions during the week can still reduce their risk of mortality.
Prescription rates for statins were dependent on age among patients with severe dyslipidemia.
Researchers examined the association between statin use and the risk of uterine fibroids and fibroid-related symptoms.
The use of a decision aid in patients at risk of acute coronary syndrome increased patient knowledge about their risk.
Depending on race, sex, and ethnicity, the right statin type may lower the risk of Alzheimer disease.
Drinking small amounts of alcohol may increase the risk of atrial fibrillation.
Researchers sought to determine the risk of venous thromboembolism associated with use of testosterone treatment.
The prevalence of elevated blood pressure rates shifted from high-income to low- and middle-income countries.
Patients who also took either lovastatin or simvastatin had a 40% higher risk of major hemorrhage than those who took other statins.
The AHA/ACC guideline updates the 2005 recommendations on PAD management.
The reduction in thromboembolism was attenuated after accounting for competing death events.
PCSK9 inhibition produces incremental benefits on coronary disease progression in patients treated with statins.
The task force finalizes recommendations for statin therapy among adults between 40 and 75 years of age.
Ambulatory high-dose intravenous diuretic therapy could be cost saving compared with hospitalization for intravenous loop diuretic therapy.
Caffeine consumption in patients with systolic heart failure does not induce arrhythmias both at rest and during physical exercise.
One in 6 patients hospitalized for a first episode of syncope experiences a pulmonary embolism.
Depression can occur in approximately 1 in 5 patients who have chronic stable angina.
The AABB evaluated studies that examined hemoglobin thresholds for red blood cell transfusion and red blood cell storage duration.
Some individual NSAIDs may be linked to increased risk of hospital admission for heart failure.
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Statin-based therapy had a smaller effect in reducing major vascular events in patients with advanced chronic kidney disease.
Researchers found that dietary changes, other medications, and surgery can also lower cardiovascular risk.